Rare diseases
Investigational molecules
Locations
Back to Austria285 clinical trials in Salzburg, Austria across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
AustriaEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
AustriaStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
AustriaGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
AustriaA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
AustriaStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
AustriaA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
AustriaAustriaStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
AustriaStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
AustriaStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
AustriaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
AustriaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on metastatic cancers and innovative treatment approaches, including trials investigating new therapies for prostate cancer, colorectal cancer, and bladder cancer.
Multiple clinical trials evaluating targeted therapies and combination treatments for various stages of cancer progression.
Investigating breakthrough treatments for multiple myeloma and acute myeloid leukemia, with emphasis on innovative therapeutic combinations and targeted approaches.
Focus on improving outcomes for patients with various blood disorders through advanced therapeutic strategies.
Research initiatives addressing cardiovascular disease, Crohn's disease, and Alzheimer's disease, exploring new treatment modalities and therapeutic approaches.
Comprehensive studies aimed at developing more effective treatments for chronic conditions affecting quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
